News Search Results
Mar 02, 2026, 08:30 ET Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
diagnostics and therapeutics for AKI, CRRT, septic shock, vasopressor therapy, extracorporeal membrane oxygenation (ECMO), hepatorenal syndrome (HRS), COVID-19, and acute respiratory distress syndrome (ARDS). As site principal investigator or an investigator, he has enrolled approximately 300 critically ill
More news about: Talphera, Inc.
Mar 02, 2026, 07:30 ET BTQ Technologies Added to WisdomTree Quantum Computing Fund (WQTM), Expanding U.S. Thematic ETF Exposure
conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays
More news about: BTQ Technologies Corp.
Mar 02, 2026, 07:00 ET HIGHWAY HOLDINGS REPORTS FISCAL YEAR 2026 THIRD QUARTER AND NINE MONTH RESULTS
governmental, political and technological factors affecting the company's revenues, operations, markets, products and prices, the impact of the worldwide COVID-19 pandemic, and other factors discussed in the company's various filings with the Securities and Exchange Commission, including without limitation,
More news about: Highway Holdings Limited
Mar 02, 2026, 07:00 ET Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results
costs and final settlement for some of our acquisitions, and severance fees incurred, partially offset by employer retention tax credits related to COVID-19 relief.(2)
More news about: Astrana Health, Inc.
Feb 27, 2026, 12:28 ET Great American Media CEO Bill Abbott Shares Vision to Reclaim the American Family with NRB President Troy Miller at Annual NRB Convention
Great American Family, during one of the most challenging periods in television history -- the height of the COVID-19 pandemic and a dramatic decline in cable viewers as streaming platforms rose to prominence. Despite early headwinds, the company quickly established
More news about: Great American Media
Feb 27, 2026, 11:07 ET LAVERNE COX & AMBER RILEY JOIN THE ELIZABETH TAYLOR AIDS FOUNDATION AHEAD OF FEB. 28 HIV IS NOT A CRIME AWARENESS DAY
people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. In 2025, Gilead announced a planned $32 billion investment to further strengthen its U.S. footprint to power the next era
More news about: The Elizabeth Taylor AIDS Foundation
Feb 27, 2026, 08:11 ET Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata
therapy and in the U.S., Europe and Japan for adult patients with severe AA. Marketing authorization for the treatment of hospitalized patients with COVID-19 has been granted for baricitinib in multiple countries.The U.S. FDA-approved labeling for Olumiant includes a Boxed Warning for Serious Infections,
More news about: Eli Lilly and Company
Feb 26, 2026, 16:26 ET Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
and Horizon. Biosecurity revenue is generated from fees for data, analytics, and services. Prior to 2024, Biosecurity revenue also included sales of COVID-19 diagnostic and sample collection test kits.The Company's reportable segments are those for which discrete financial information is available
More news about: Ginkgo Bioworks
Feb 26, 2026, 11:58 ET Zephyr Releases PSN Top Guns List for Q4 2025, Highlighting Best-In-Class Separate Accounts, Managed Accounts and Managed ETF Strategies
"These managers have successfully steered through transformative events such as the COVID-19 pandemic market crash, the Brexit referendum, the US-China trade war, and the global sell-off of 2015-2016," says PSN Product Manager Nick Williams.
More news about: Zephyr, an Informa Company
Feb 26, 2026, 11:30 ET Children's Hospital of Philadelphia and Penn Medicine Launch First CRISPR-Based Platform to Pinpoint Drivers of Acute Myeloid Leukemia in Patient Cells
innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.The University of Pennsylvania Health System's patient care facilities stretch from the Susquehanna River in Pennsylvania to the New
More news about: Children's Hospital of Philadelphia
Feb 26, 2026, 08:36 ET Ryan Hartsell Named 2025 Texas Commercial Real Estate Icon by REDnews
and focused on building institutional-grade systems within an independent brokerage framework. The firm expanded its industrial practice during the COVID-19 market shift and implemented technology-driven processes that increased efficiency and data transparency for clients.Hartsell has developed
More news about: Oxford Partners
Feb 26, 2026, 08:00 ET Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
1/2 data from their influenza-COVID-19 combination programs and their belief that these data support the high probability of demonstrating non-inferiority in Phase 3 trials that would compare the new vaccine against the widely used regimen where both the flu and COVID-19 vaccines are co-administered.Sanofi
More news about: Novavax, Inc.
Feb 26, 2026, 07:30 ET Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease
candidate, as well as our vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax™, our vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2). The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known
More news about: SOLIGENIX, INC.
Feb 26, 2026, 06:30 ET United Parks & Resorts Inc. Reports Fourth Quarter and Fiscal 2025 Results
%COVID-19 related incremental costs (h)
More news about: United Parks and Resorts Inc.
Feb 25, 2026, 19:04 ET Genomma Lab Internacional Announces Results for the Fourth Quarter and Full Year 2025
forward-looking statements, which speak only as of their dates. Risks and uncertainties include, but are not limited to: risks related to the impact of the COVID19 global pandemic, such as the scope and duration of the outbreak, government actions and restrictive measures implemented in response, material delays,
More news about: Genomma Lab Internacional, S.A.B. de C.V.
Feb 25, 2026, 18:16 ET Differing immune responses in infants may explain increased severity of RSV over SARS-CoV-2
infants hospitalized with respiratory syncytial virus (RSV) often become much sicker compared to those infected with SARS-CoV-2, the virus that causes COVID-19. In a study published today in Science Translational Medicine, scientists from St. Jude Children's Research Hospital and The Jackson Laboratory
More news about: St. Jude Children's Research Hospital
Feb 25, 2026, 15:54 ET AMFA WINS REPRESENTATION ELECTION AT ALASKA AIRLINES AND HAWAIIAN AIRLINES
Airlines, Horizon Air, Southwest Airlines, WestJest Airlines, and Calm Air, with proven success protecting jobs during industry disruptions, including the COVID-19 pandemic and airline mergers."This election win represents confidence of maintenance professionals in AMFA's ability to deliver meaningful
More news about: Aircraft Mechanics Fraternal Association
Feb 25, 2026, 09:00 ET 揭示腸道細菌與癌症治療關聯性的研究榮膺 Bial 生物醫學獎，獲頒 35 萬歐元獎金
項提名，涵蓋癌症、傳染病及神經退化性疾病等領域。 歷屆獲得表彰的傑出研究成果，後來都贏得了蜚聲國際的科學獎項。 值得注意的是，兩位曾於 2021 年獲得「BIAL 生物醫學獎」的科學家 Katalin Karikó 與 Drew Weissman，榮獲了 2023 年諾貝爾生理學或醫學獎以表彰他們的發現，讓研發能有效防治 COVID-19 的 mRNA 疫苗成為現實。
More news about: Bial Foundation
Feb 25, 2026, 09:00 ET Entdeckung zum Zusammenhang zwischen Darmbakterien und Krebstherapie gewinnt den Bial Award in Biomedicine und erhält 350.000 Euro Preisgeld
2023 den Nobelpreis für Physiologie oder Medizin für ihre Entdeckungen, die die Entwicklung wirksamer mRNA-basierter Impfstoffe zur Prävention von COVID-19 ermöglichten.Foto - https://mma.prnewswire.com/media/2919779/Bial_Award.jpgLogo
More news about: Bial Foundation
Feb 25, 2026, 09:00 ET 腸内細菌とがん治療の関連を解明した発見が「BIAL生物医学賞（BIAL Award in Biomedicine）」を受賞、35万ユーロを獲得
、後に権威ある国際的な科学賞を受賞しています。特筆すべきことに、2021年にBIAL生物医学賞（BIAL Award in Biomedicine）を受賞した2人の科学者、Katalin Karikó氏とDrew Weissman氏は、COVID‑19を予防する効果的なmRNAワクチンの開発を可能にした発見により、2023年のノーベル生理学・医学賞を受賞しました。写真：https://mma.prnewswire.com/media/2919779/Bial_Award.jpgロゴ：
More news about: Bial Foundation
Feb 25, 2026, 09:00 ET Descoberta ligando bactérias intestinais ao tratamento do câncer vence o Prêmio Bial em Biomedicina e recebe € 350.000
Fisiologia ou Medicina de 2023 por suas descobertas que possibilitaram o desenvolvimento de vacinas eficazes baseadas em mRNA para prevenir a COVID-19.Foto - https://mma.prnewswire.com/media/2919779/Bial_Award.jpgLogotipo
More news about: Bial Foundation
Feb 25, 2026, 09:00 ET El descubrimiento que vincula las bacterias intestinales con el tratamiento del cáncer gana el Premio Bial
Nobel de Fisiología o Medicina 2023 por sus descubrimientos que permitieron el desarrollo de vacunas eficaces basadas en ARNm para prevenir la COVID-19.Foto - https://mma.prnewswire.com/media/2919779/Bial_Award.jpgLogo
More news about: Bial Foundation
Feb 25, 2026, 09:00 ET El descubrimiento que vincula las bacterias intestinales con el tratamiento contra el cáncer gana el premio Bial en Biomedicina y recibe un galardón de 350.000 euros
Fisiología o Medicina 2023 por sus descubrimientos que permitieron el desarrollo de vacunas efectivas basadas en ARNm para prevenir la enfermedad de COVID-19.Foto - https://mma.prnewswire.com/media/2919779/Bial_Award.jpgLogotipo
More news about: Bial Foundation
Feb 25, 2026, 09:00 ET Une découverte liant les bactéries intestinales au traitement du cancer remporte le prix Bial Award in Biomedicine et se voit attribuer une somme de 350 000 EUR
prix Nobel de physiologie ou médecine en 2023 pour leurs découvertes ayant permis le développement de vaccins à base d'ARNm efficaces contre la COVID-19.Photo - https://mma.prnewswire.com/media/2919779/Bial_Award.jpgLogo
More news about: Bial Foundation
Feb 25, 2026, 08:10 ET VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution
doi: 10.1186/s13613-023-01204-y.Morimont, L., et al. (2022). NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study. Biomolecules, 12(8), 1038. doi: 10.3390/biom12081038Bouazzi
More news about: VolitionRx Limited